• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

专家的代理问题:来自日本处方药市场的证据。

Experts' agency problems: evidence from the prescription drug market in Japan.

作者信息

Iizuka Toshiaki

出版信息

Rand J Econ. 2007 Autumn;38(3):844-62. doi: 10.1111/j.0741-6261.2007.00115.x.

DOI:10.1111/j.0741-6261.2007.00115.x
PMID:18478669
Abstract

This article examined the physician-patient agency relationship in the context of the prescription drug market in Japan. In this market, physicians often both prescribe and dispense drugs and can pocket profits in so doing. A concern is that, due to the incentive created by the mark-up, physicians' prescription decisions may be distorted. Empirical results using anti-hypertensive drugs suggest that physicians' prescription choices are influenced by the mark-up. However, physicians are also sensitive to the patient's out-of-pocket costs. Overall, although the mark-up affects prescription choices, physicians appear more responsive to the patient's out-of-pocket costs than their own profits from mark-up.

摘要

本文考察了日本处方药市场背景下的医患委托代理关系。在这个市场中,医生常常既开处方又配药,并能从中获利。一个担忧是,由于加价所产生的激励,医生的处方决策可能会受到扭曲。使用抗高血压药物的实证结果表明,医生的处方选择受到加价的影响。然而,医生也对患者的自付费用很敏感。总体而言,尽管加价会影响处方选择,但比起自己从加价中获得的利润,医生似乎对患者的自付费用更敏感。

相似文献

1
Experts' agency problems: evidence from the prescription drug market in Japan.专家的代理问题:来自日本处方药市场的证据。
Rand J Econ. 2007 Autumn;38(3):844-62. doi: 10.1111/j.0741-6261.2007.00115.x.
2
Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching.行业支付与长效胰岛素处方之间的关联:一项基于倾向评分匹配的观察性研究。
PLoS Med. 2021 Jun 1;18(6):e1003645. doi: 10.1371/journal.pmed.1003645. eCollection 2021 Jun.
3
Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.分析发现,接受药企资金的医生更有可能开品牌药。
BMJ. 2016 Mar 21;352:i1645. doi: 10.1136/bmj.i1645.
4
Financial incentives and physician prescription behavior: Evidence from dispensing regulations.经济激励与医生处方行为:来自配药规定的证据。
Health Econ. 2019 Sep;28(9):1114-1129. doi: 10.1002/hec.3893. Epub 2019 Jul 1.
5
Physicians, pharmaceutical sales representatives, and the cost of prescribing.医生、药品销售代表与开药成本
Arch Fam Med. 1996 Apr;5(4):201-6. doi: 10.1001/archfami.5.4.201.
6
Do drug costs affect physicians' prescription decisions?药品成本会影响医生的处方决策吗?
J Intern Med. 1997 May;241(5):415-20. doi: 10.1046/j.1365-2796.1997.137143000.x.
7
Financial incentives and the prescription of newer vaccines by doctors in India.印度医生的经济激励措施与新型疫苗的处方情况
Indian J Med Ethics. 2010 Jan-Mar;7(1):28-30. doi: 10.20529/IJME.2010.010.
8
Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.医药行业支付与高成本药物处方之间的关联:一项使用公开支付数据和医疗保险D部分数据的观察性研究。
BMC Health Serv Res. 2018 Apr 2;18(1):236. doi: 10.1186/s12913-018-3043-8.
9
Corruption practices in drug prescribing in Vietnam - an analysis based on qualitative interviews.越南药品处方中的腐败行为——基于定性访谈的分析
BMC Health Serv Res. 2018 Jul 28;18(1):587. doi: 10.1186/s12913-018-3384-3.
10
Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?哮喘患者的福利计划设计与处方药使用情况:患者自付费用重要吗?
Front Health Policy Res. 2004;7:95-127. doi: 10.2202/1558-9544.1053.

引用本文的文献

1
Breaking brand: an observational study on pharmacy-hospital-patient relationships and generic drug utilisation in Japan.打破品牌:日本药房 - 医院 - 患者关系与仿制药使用情况的观察性研究
BMJ Open. 2025 May 21;15(5):e093601. doi: 10.1136/bmjopen-2024-093601.
2
To introduce or not? Strategic analysis of hospital operations with telemedicine.引入还是不引入?远程医疗在医院运营中的策略分析。
Eur J Oper Res. 2023 Jan 1;304(1):292-307. doi: 10.1016/j.ejor.2021.12.020. Epub 2021 Dec 16.
3
Generic Drug Usage in Dentistry across Japan: Analysis Using a Japanese National Database.
日本牙科中通用名药物的使用情况:基于日本全国数据库的分析。
Int J Environ Res Public Health. 2021 Oct 28;18(21):11329. doi: 10.3390/ijerph182111329.
4
Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China.零差价药品政策对县综合医院和中医院的不同影响:来自中国山东省的证据。
Int J Equity Health. 2020 Dec 10;19(1):219. doi: 10.1186/s12939-020-01326-w.
5
Understanding profit margins of medical providers from prescription drugs: evidence from Taiwan.理解医疗服务提供者从处方药中获得的利润率:来自台湾的证据。
Int Health. 2020 Jul 1;12(4):272-280. doi: 10.1093/inthealth/ihz072.
6
Penetration of new antidiabetic medications in East Asian countries and the United States: A cross-national comparative study.新的抗糖尿病药物在东亚国家和美国的渗透:一项跨国比较研究。
PLoS One. 2018 Dec 12;13(12):e0208796. doi: 10.1371/journal.pone.0208796. eCollection 2018.
7
The medical assistance system and inpatient health care provision: Empirical evidence from short-term hospitalizations in Japan.医疗援助制度与住院医疗服务提供:来自日本短期住院的经验证据。
PLoS One. 2018 Oct 4;13(10):e0204798. doi: 10.1371/journal.pone.0204798. eCollection 2018.
8
A chronological pharmacovigilance network analytics approach for predicting adverse drug events.一种用于预测药物不良事件的时间顺序药物警戒网络分析方法。
J Am Med Inform Assoc. 2018 Oct 1;25(10):1311-1321. doi: 10.1093/jamia/ocy097.
9
Patient Copayments, Provider Incentives and Income Effects: Theory and Evidence from the Essential Medications List under China's 2009 Healthcare Reform.患者自付费用、医疗机构激励措施与收入效应:来自中国2009年医疗改革基本药物目录的理论与证据
World Med Health Policy. 2017 Mar;9(1):24-44. doi: 10.1002/wmh3.222. Epub 2017 Mar 16.
10
How Social Preferences Shape Incentives in (Experimental) Markets for Credence Goods.社会偏好如何塑造(实验性)信任品市场中的激励机制。
Econ J (London). 2017 Mar;127(600):393-416. doi: 10.1111/ecoj.12284. Epub 2016 Feb 23.